Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
Global Radiopharmaceuticals Market 2023-2029
... the therapy of diseases. Radiopharmaceuticals may be given to the patient in several different ways. For example, they may be given by mouth, given by injection, or placed into the eye or into the bladder. ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... Media industry is expected to register solid growth in the sector in 2023 and beyond. The Diagnostic Radiopharmaceuticals and Contrast Media market report analyzes the Diagnostic Radiopharmaceuticals and Contrast Media market growth opportunities, trends, insights, ... Read More
-
Radiopharmaceuticals Market Intelligence Report - Global Forecast 2023-2030
... Market Statistics: The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029
... the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. LPI (LP Information)' newest research report, ... Read More
-
Global Radiopharmaceuticals Market Growth 2023-2029
... The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2023-2029
... properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the ... Read More
-
Global Radiopharmaceutical Market Growth 2023-2029
... The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and ... Read More
-
Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2027
... (Pet) {Flourine-18, Carbon-11, Gallium-68, And Others}], Therapeutic Products [Alpha Emitters {Astatine-211, Actinium-225, Lead-212, And Others}, Beta Emitters {Lutetium-177, Iodine-131, Yttrium-90, And Others}, And Brachytherapy]), By Application (Cardiology, Neurology, Oncology, And Others), By End-User (Hospitals, Diagnostic ... Read More
-
Global Radiopharmaceuticals Market - 2022-2029
... 2022 to 2029. Radiopharmaceuticals contain radioactive substances used to diagnose or treat diseases, including cancer or cardiology. These are used for the diagnosis of abscess and infection, blood vessel diseases, bone diseases, colorectal disease and ... Read More
-
Global SPECT Radiopharmaceuticals Market Research Report 2021-2032
... provide a comprehensive outlook of the global market. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “SPECT Radiopharmaceuticals Market”. Key Companies Profiled in the ... Read More
-
Nuclear Medicine/Radiopharmaceuticals Market Analysis And Forecast To 2031: By Type (Diagnostics, {SPECT, PET}, Therapeutics {Alpha Emitters, Beta Emitters, Brachytherapy}), By Application (Oncology, Cardiology, Neurology, Orthopedics, Thyroid) And Region
... at USD 7.8 billion in 2021 and it is anticipated to grow up to USD 48.8 billion by 2031, at a CAGR of 20.1% during the forecast period. Nuclear medicine is primarily a specialized area ... Read More
-
Radiopharmaceuticals & Stable Isotopes Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type
... 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price ... Read More
-
Radiopharmaceuticals Market Intelligence Report - Global Forecast to 2027
... period. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is ... Read More
-
Oncology Radiopharmaceuticals Market, by Test Type (Radium-223 dichloride, Sodium iodide I-131, Lobenguane iodine-131, Lutetium-177, Yttrium-90, Fludeoxyglucose F 18, Gallium Citrate Ga 67, Technetium-99m, and Others), by Route of Administration (Oral and
... and Treatment), by End User (Diagnostic Centres, Hospitals and Clinics, and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 ... Read More
-
Global Nuclear Medicine & Radiopharmaceuticals Market 2022-2028
... these radioactive tracers. Garnering a CAGR of 10.4% from 2022 to 2028, the global nuclear medicine & radiopharmaceuticals market is projected to reach worth of USD 17,878 million by 2028-end, according to a new report ... Read More
-
Global Radiotherapy, Nuclear Medicine & Radiopharmaceuticals Market 2022-2028
... multiplying. Therapeutic radiology may be used to cure or control cancer, or to alleviate some of the symptoms associated with cancer. Gen Consulting Company predicts that the global radiotherapy, nuclear medicine & radiopharmaceuticals market is ... Read More
-
Peptide Receptor Radionuclide Therapy (PRRT) Market, by Drug Type (Lutetium (Lu-177)-based), by Disease Indication (Pancreatic - Neuroendocrine Tumor, Gastrointestinal Tract - Neuroendocrine Tumor, and Others), by Distribution Channel (Hospital Pharmacies
... Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Peptide receptor radionuclide therapy (PRRT) is a molecular therapy (radioisotope therapy) used for ... Read More
-
Radiopharmaceuticals in Nuclear Medicine Market, By Product Type (Diagnostic Nuclear Medicine (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals) and Therapeutic Nuclear Medicine), By Application (Oncology, Cardiology, Neurology, Endocrinology, and
... Diagnostic Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Therapeutic applications of radiopharmaceuticals include treatment of specific cancers ... Read More
-
Global Nuclear Medicine/Radiopharmaceuticals Market Size study, By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), By Application (SPECT Applications, PET Applications, Therapeutic Applications), By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures), and Regional Forecasts 2022-2028
... 2022-2028 Global Nuclear Medicine/Radiopharmaceuticals Market is valued approximately USD 4.80 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2028. Nuclear medicine is ... Read More
-
Global Theranostics Market 2022-2028
... second radioactive drug to deliver therapy to treat the main tumor and any metastatic tumors. According to Gen Consulting Company, the global theranostics market is projected to reach USD 123,694 million, recording a CAGR of ... Read More
-
2022 Global Forecast for Radiation Dose Management (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Nuclear Medicine/Radiopharmaceuticals (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Radiopharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Type: Diagnostic; Therapeutic 2) By Application: Oncology; Cardiology; Neuroendocrinology; Nephrology; Musculoskeletal; Respiratory; Others 3) By End-User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes Covering: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE); IBA Group
... market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies. Understand how the market is ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)
... The COVID-19 pandemic is expected to have impacted the growth of the studied market. According to the research study published in the Journal of Nuclear Medicine, in July 2020, many countries were experiencing radiopharmaceutical supply ... Read More
Research Assistance
